Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Biomed Research International|June 16, 2015
Acute intermittent porphyria in Argentina: an updateGabriela Nora Cerbino, Esther Noemí Gerez, Laura Sabina Varela, et al.Journal of Photochemistry and Photobiology. B, Biology|June 30, 2009
Comparation of liposomal formulations of ALA Undecanoyl ester for its use in photodynamic therapyGabriela Di Venosa, Laura Hermida, Haydée Fukuda, et al.Journal of Photochemistry and Photobiology. B, Biology|August 4, 2009
Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapyLorena Rodriguez, Henriëtte S de Bruijn, Gabriela Di Venosa, et al.Molecular Medicine (Cambridge, Mass.)|August 21, 2009
Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyriaVictoria E Parera, Rita H Koole, Gardi Minderman, et al.JIMD Reports|February 23, 2013
Functional Characterization of Five Protoporphyrinogen oxidase Missense Mutations Found in Argentinean Variegate Porphyria PatientsManuel Méndez, Barbara X Granata, María J Morán Jiménez, et al.The International Journal of Biochemistry & Cell Biology|December 3, 2003
Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cellsAna María Buzaleh, María García-Bravo, Susana Navarro, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|July 30, 2016
Pleiotropic effects of 5-aminolevulinic acid in mouse brainJimena Lavandera, Jorge Rodríguez, Silvina Ruspini, et al.Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|October 31, 2012
Light fractionated ALA-PDT enhances therapeutic efficacy in vitro; the influence of PpIX concentration and illumination parametersHenriëtte S de Bruijn, Adriana G Casas, Gabriela Di Venosa, et al.The International Journal of Biochemistry & Cell Biology|May 18, 2005
Effects of repeated administration with CP-55,940, a cannabinoid CB1 receptor agonist on the metabolism of the hepatic hemeAntonio Fontanellas, Jorge Manzanares, María García-Bravo, et al.Cancer Letters|July 30, 2008
Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapyAdriana Casas, Gabriela Di Venosa, Silvia Vanzulli, et al.Pageof 7